Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.

Saved in:
Bibliographic Details
Title: Patient satisfaction with ExtaviPro™ 30G, a new auto-injector for administering interferon β-1b in multiple sclerosis: results from a real-world, observational EXCHANGE study.
Authors: Hoffmann FA; Department of Neurology, Hospital Martha-Maria Halle-Dölau, Halle, Germany., Trenova A; Department of Neurology, Medical University of Plovdiv, Plovdiv, Bulgaria., Llaneza MA; Neurology Department, Ferrol University Hospital, Ferrol, Spain., Fischer J; Neurologische Praxis (NTDStudy-Group), Lappersdorf, Germany., Lus G; Multiple Sclerosi Center university of Campania L. Vanvitelli, Naples, Italy., von Bredow D; QuintilesIMS, IMS Health GmbH & Co. OHG, Munich, Germany., Lara N; QuintilesIMS, Barcelona, Spain., Lam E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Van Hoef M; Novartis Pharma AG, Fabrikstrasse 12-3.03.12, Postfach, CH-4002, Basel, Switzerland., Bakshi R; Novartis Pharma AG, Fabrikstrasse 12-3.03.12, Postfach, CH-4002, Basel, Switzerland. rajesh.bakshi@novartis.com.
Source: BMC neurology [BMC Neurol] 2017 Aug 09; Vol. 17 (1), pp. 156. Date of Electronic Publication: 2017 Aug 09.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377 (Electronic) Linking ISSN: 14712377 NLM ISO Abbreviation: BMC Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2377
DOI:10.1186/s12883-017-0928-9